Pediatric Hematologist-Oncologist: Natalie Kamberos, DO | Loyola Medicine

Natalie Kamberos, DO, FAAP

Pediatrics

Pediatric Hematology/Oncology
Assistant Professor

Languages Spoken

English, Spanish (intermediate)

Clinical Expertise

  • Anemia
  • Bleeding Disorders In Children And Adolescents
  • Blood Diseases (Benign)
  • Leukemia
  • Lymphoma
  • Sickle Cell Disease

About Dr. Kamberos

Interests
Medical Missions and Outreach Work, Baking, Cubs baseball, Singing, Dogs

Medical Education

Medical School
Kansas City University of Medicine and Biosciences
Residency
Blank Children's Hospital - Pediatrics
Fellowship
  • University of Iowa Hospitals and Clinics - Pediatrics

Board Certification

American Board of Pediatrics
Pediatric Hematology Oncology, American Board of Pediatrics Subspecialty, Pediatric Hematology & Oncology

Research

  • CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma. Han, SS; Tompkins, VS; Son, DJ; Han, S; Yun, H; Kamberos, NL; Dehoedt, CL; Gu, C; Holman, C; Tricot, G; Zhan, F; Janz, S, Experimental hematology & oncology
  • A new model of LMP1-MYC interaction in B cell lymphoma. Ontiveros, EP; Halwani, A; Stunz, LL; Kamberos, N; Olivier, AK; Janz, S; Bishop, GA, Leukemia & lymphoma
  • Choroidal schwannoma in a 6-month-old girl. Chen, JJ; Kamberos, NL; O'Dorisio, MS; Syed, NA; Boldt, C, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
View All ResearchShow Less
  • Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance. Han, SS; Han, S; Kamberos, NL, Biochemical and biophysical research communications